Hutchison China MediTech (HCM) is Initiated by BofA/Merrill to Buy

Hutchison China MediTech (HCM) was Initiated by BofA/Merrill to “Buy”. BofA/Merrill advised their investors in a research report released on Apr 11, 2016.

Hutchison China MediTech

Leave a Reply

Hutchison China MediTech - Is it time to Sell?

Top Brokerage Firms are advising their investors on Hutchison China MediTech. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.